Benefits and Effectiveness of Administering Pneumococcal Polysaccharide Vaccine With Seasonal Influenza Vaccine: An Approach for Policymakers
- 1 April 2012
- journal article
- review article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 102 (4), 596-605
- https://doi.org/10.2105/ajph.2011.300512
Abstract
For the influenza pandemic of 2009–2010, countries responded to the direct threat of influenza but may have missed opportunities and strategies to limit secondary pneumococcal infections. Delivering both vaccines together can potentially increase pneumococcal polysaccharide vaccine (PPV23) immunization rates and prevent additional hospitalizations and mortality in the elderly and other high-risk groups. We used PubMed to review the literature on the concomitant use of PPV23 with seasonal influenza vaccines. Eight of 9 clinical studies found that a concomitant program conferred clinical benefits. The 2 studies that compared the cost-effectiveness of different strategies found concomitant immunization to be more cost-effective than either vaccine given alone. Policymakers should consider a stepwise strategy to reduce the burden of secondary pneumococcal infections during seasonal and pandemic influenza outbreaks.Keywords
This publication has 52 references indexed in Scilit:
- Co-detection of Pandemic (H1N1) 2009 Virus and Other Respiratory PathogensEmerging Infectious Diseases, 2010
- 2009 Pandemic Influenza A (H1N1): Pathology and Pathogenesis of 100 Fatal Cases in the United StatesThe American Journal of Pathology, 2010
- Impact of the 2009 influenza pandemicThorax, 2010
- Expansion of seasonal influenza vaccination in the AmericasBMC Public Health, 2009
- Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: A systematic review of conclusions and assumptionsVaccine, 2009
- Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza PreparednessThe Journal of Infectious Diseases, 2008
- Deaths from Bacterial Pneumonia during 1918–19 Influenza PandemicEmerging Infectious Diseases, 2008
- Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasonsBMC Public Health, 2008
- Herd immunity and pneumococcal conjugate vaccine: A quantitative modelVaccine, 2007
- Insights into the Interaction between Influenza Virus and PneumococcusClinical Microbiology Reviews, 2006